Chapter PDF
Keywords
- Stem Cell
- Umbilical Cord Blood
- Total Body Irradiation
- Graft Versus Host Disease
- Hematopoietic Cell Transplantation
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Oakley EJ, Vant Zant G. Unraveling the complex regulation of stem cells: implications for aging and cancer. Leukemia 2007;21:612–21
Papayannapoulou T. Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization. Blood 2004;103:1580–5
Rocha V, Labopin M, Sanz G et al. Transplants of umbilical cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004;351:2276–85
Sauvageau G, Iscove NN, Humphries RK. In vitro and in vivo expansion of hematopoietic stem cells. Oncogene 2004;23:7223–32
Siena S, Schiavo R, Pedrazzoli P et al. Therapeutic relevance of CD34+ cell dose in blood cell transplantation for cancer therapy. J Clin Oncol 2000;18:1360–77
Sorrentino BP. Clinical strategies for expansion of haematopoietic stem cells. Nat Rev Immunol 2004;4:878–88
Weissman IL. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 2000;287:1442–6
http://stemcells.alphamedpress.org/ Stem Cells
http://www.marrow.org/ National Marrow Donor Program
http://www.bmtinfonet.org/ BMT InfoNet
http://stemcells.nih.gov/index.asp NIH Stem Cell Info
http://stemcell.princeton.edu Stem Cell Database
Antin JH. Long-term care after hematopoietic cell transplantation in adults. N Engl J Med 2002;347:36–42
Devetten M, Armitage JO. Hematopoietic cell transplantation: progress and obstacles. Ann Oncol 2007;18:1450–6
Gratwohl A, Baldomero H, Frauendorfer K et al. EBMT activity survey 2004 and changes in disease indication over the past 15 years. Bone Marrow Transpl 2006;37:1069–85
Jansen J, Hanks S, Thompson JM et al. Transplantation of hematopoietic stem cells from the peripheral blood. J Cell Mol Med 2005;9:37–50
Kessinger A, Sharp JG. The whys and hows of haematopoietic progenitor and stem cell mobilization. Bone Marrow Transpl 2003;31:319–29
Majhail NS, Ness KK, Burns LJ et al. Late effects in survivors of Hodgkin’s and Non-Hodkin’s lymphoma treated with autologous hematopoietic cell transplantation. Biol Blood Marrow Transpl 2007;13:1–7
http://www.ebmt.org EBMT, Eur Grp Blood Marrow Transpl
http://www.ibmtr.org Blood Marrow Transpl Registry
http://www.asbmt.org/ Am Soc Blood Marrow Transpl
http://www.bmtnet.org/ Blood Marrow Transpl Net
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr4910a1.htm CDC, Guidelines
http://www.emedicine.com/ped/topic2593.htm E-medicine
Appelbaum FR. Dose intensity and the toxicity and efficacy of allogeneic hematopoietic cell transplantation. Leukemia 2005;19:171–5
Bertz H, Potthoff K, Finke J. Allogeneic stem-cell transplantation from related and unrelated donors in older patients with myeloid leukemia. J Clin Oncol 2003:21:1480–4
Butcher BW, Collins RH. The graft-versus-lymphoma-effect: clinical review and future opportunities. Bone Marrow Transplant 2005;36:1–17
Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006;354:1813–26
Deeg HJ. How I treat refractory acute GVHD. Blood 2007;109:4119–26
Grathwohl A, Baldomero H, Frauendorfer K et al. Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors. Bone Marrow Transplant 2007;39:71–87
Schoemans H, Theunissen K, Maertens J et al. Adult umbilical cord blood transplantation. Bone Marrow Transplant 2006;38:83–93
http://www.ebmt.org EBMT, Eur Grp Blood Marrow Transpl
http://www.asbmt.org ASBMT, Am Soc Blood Marrow Transpl
http://www.bmtnet.org Blood and Marrow Transplant Network
http://www.nature.com/bmt/index.html Bone Marrow Transpl Journal
http://www.bmtinfonet.org Blood and Marrow Transplant Information
http://www.bloodline.net Bloodline, Hematology Education
http://www.marrow.org National Marrow Donor Program
http://www.ibmtr.org International Bone Marrow Transplant Registry
Hübel K, Engert A. Granulocyte transfusion therapy for treatment of infections after cytotoxic chemotherapy. Onkologie 2003;26:73–9
Mousset S, Hermann S, Klein SA et al. Prophylactic and interventional granulocyte transfusion in patients with haematological malignancies and life-threatening infections during neutropenia. Ann Hematol 2005;84:234–41
Price TH. Granulocyte transfusion: current status. Semin Hematol 2007;44:15–23
Robinson SP, Marks DI. Granulocyte transfusions in the G-CSF era. Where do we stand? Bone Marrow Transplant 2004;34:839–46
http://www.aabb.org/ American Association of Blood Banks
Banchereau J, Palucka A. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 2005;5:296–306
Blattmann JN, Greenberg PD. Cancer immunotherapy: a treatment for the masses. Science 2004;305:200–5
Brentjens RJ, LAtouche JB, Santos E et al. Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15. Nat Med 2003;9:279–86
Lake RA, Robinson BW. Immunotherapy and chemotherapy: a practical partnership. Nat Rev Cancer 2005;5:397–405
Mapara MY, Sykes M. Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance. J Clin Oncol 2004;22:1136–51
Ribas A, Butterfiled LH, Glaspy JA et al. Current developments in cancer vaccines and cellular immunotherapy. J Clin Oncol 2003;21:2415–32
Steinmann RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007;449:419–26
http://www.cancerresearch.org Cancer Research Institute
http://www.cancersupportivecare.com/immunotherapy.html Cancer Immunotherapy
http://www.meds.com/immunotherapy/intro.html Immunotherapy Training
http://www.cancerimmunotherapy.org Assoc Immunother Cancer
http://www.meniscus.com/horizons/2-1.pdf Cancer Immunotherapy
Baum C, Düllmann J, Li Z et al. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 2003;101:2099–114
Eder IE, Haag P, Bartsch G et al. Gene therapy strategies in prostate cancer. Curr Gene Ther 2005;5:1–10
Lusky M. Good manufacturing practice production of adenoviral vectors for clinical trials. Hum Gene Ther 2005;16:281–91
Manilla P, Rebello T, Afable C et al. Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector. Hum Gene Ther 2005;16:17–25
Nathawani AC, Davidoff AM, Linch DC. A review of gene therapy for haematological disorders. Br J Haematol 2005;128:3–17
Neff T, Beard BC, Kiem HP et al. Survival of the fittest: in vivo selection and stem cell gene therapy. Blood 2006;107:1751–60
http://www.esgct.org/ European Society of Gene Therapy
http://www.asgt.org/ American Society of Gene Therapy
http://www.iscgt.org.uk/ Intl Society for Cancer Gene Therapy
http://www.mdanderson.org/departments/genetherapy/ MD Anderson Gene Therapy Center
http://www.euregenethy.org European Gene Therapy Network
http://www.cancer.gov/cancertopics/ factsheet/Therapy/gene/ NCI, Cancernet
Carmeliet P. Angiogenesis in health and disease. Nature Med 2003;6:653–60
Fayette J, Soria JC, Armand JP et al. Use of angiogenesis inhibitors in tumour treatment. Eur J Cancer 2005;41:1109–16
Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nature Med 2003;9:669–76
Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002;6(suppl 16):15–18
Keyhani A, Jendiroba DB, Freireich EJ. Angiogenesis and leukemia. Leuk Res 2001;25:639–45
Podar K, Anderson KC. The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications. Blood 2005;105:1383–95
Timar J, Dome B, Fazekas K et al. Angiogenesis-dependent diseases and angiogenesis therapy. Pathol Oncol Res 2001;7:85–94
Tozer GM, Kanthou C, Baguley BC. Disrupting tumour blood vessels. Nat Rev Cancer 2005;5:423–35
http://www.oncolink.upenn.edu/ Oncolink
http://www.angio.org/ Angiogenesis Foundation
http://www.cancer.gov/clinicaltrials/developments/anti-angio-table NCI, Angiogenesis Inhibitors
http://www.cancer.gov/cancertopics/ understandingcancer/angiogenesis NCI, Angiogenesis Tutorial
http://www.angioworld.com/angiogenesis.htm Angioworld
Bhalla KN. Heat shock protein 90 modulators in hematologic neoplasms. ASCO Educational Book 42nd Annual Meeting, 2006, pp 141–6
Buckingham S. The major world of microRNAs. Horizon Symposia. Understanding the RNAissance. May 2003. Nature Publishing Group
Carter TA et al. Inhibition of drug resistant mutants of Abl, Kit, and EGF receptor kinases. Proc Natl Acad Sci 2005;102:11011–16
Dorsett Y, Tuschl T. siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov 2004;3:318–29
Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006;6:259–69
Keen N, Taylor S. Aurora-kinase inhibitors as anticancer agents. Nat Rev Cancer 2004;4:927–36
Kelland LR. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics: current status and future prospects. Eur J Cancer 2005;41:971–9
Krutzfeldt J et al. Silencing of microRNAs in vivo with “antagomirs”. Nature 2005;438:685–9
Shay JW, Wright WE. Telomerase therapeutics for cancer: challenges and new directions. Nat Rev Drug Discov 2006;5:577–84
Solit DB. Heat shock protein 90 as therapeutic target in solid tumors. ASCO Educational Book 42nd Annual Meeting, 2006, pp 136–40
Stevenson M. Therapeutic potential of RNA interference. New Engl J Med 2004;351:1772–7
http://www.rnaiweb.com The RNAi Web
http://microrna.sanger.ac.uk/ miRBase
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Deschler, B. et al. (2008). Particular Treatment Procedures. In: Berger, D., Engelhardt, M., Henß, H., Mertelsmann, R. (eds) Concise Manual of Hematology and Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-73277-8_5
Download citation
DOI: https://doi.org/10.1007/978-3-540-73277-8_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-73276-1
Online ISBN: 978-3-540-73277-8
eBook Packages: MedicineMedicine (R0)